Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system
Conditions
Interventions
Intervention1: CLONIDINE: comparison of sensory and motor effects of magnesium sulphate versus clonidine 1mcg/kg as an adjuvant to preservative free 0.5% lignocaine 3mg/kg in IVRA as a stat dose
Contr
Sponsors
Dr Kiran A V
Dr Sumayya E
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are posted for elective upper limb surgeries lasting ASA I and II Patients giving informed written consent.
Exclusion criteria
Exclusion criteria: Patients with coagultaion disoders sickle cell disease raynauds disease. Morbidly obese patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensory and motor effects of magnesium sulphate versus clonidine when added to lignocaine in intravenous regional anesthesia for upper limb surgeriesTimepoint: 1 Year | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the duration of post operative analgesia and frequency of rescue analgesic requirement after addition of magnesium sulphate versus clonidine to lignocaine. To describe any side effects of magnesium sulphate and clonidine.Timepoint: 24 hours | — |
Countries
India
Contacts
Public ContactDr sumayya e
Mandya Institute of Medical Sciences
Outcome results
None listed